Scott Boras says five teams are interested in Jarrod Washburn

0 Comments

UPDATE: These could be two of them. Tim Brown of Yahoo! Sports reports that the Diamondbacks and Indians are possibilities for Washburn, while the Mariners are becoming “a long shot.”

7:00 pm: Agent Scott Boras told Tom Krasovic of AOL Fanhouse that “as many as five clubs” are interested in free agent left-hander Jarrod Washburn.

“A lot of teams are interested. The reality has struck.”

This, after Washburn reportedly turned down a modest contract offer from the Mariners last month. Right. Now Boras has everyone right where he wants them. Crackerjack job, man.

Washburn was 9-9 with a 3.78 ERA and 1.19 WHIP over 28 starts last season; impressive numbers until you remember the cozy place he pitched in until July 31 and the 7.33 ERA he posted in eight starts with the Tigers. His FIP (Fielding Independent Pitching) was actually 4.58. Toss in the fact that he’s a 35-year-old left-hander who underwent knee surgery last October, and it’s no surprise to see him still out of work, or at least without the contract he and his agent desires.
 

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.